Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study

被引：0
|
作者：
Sadayoshi Ito
Naoki Kashihara
Kenichi Shikata
Masaomi Nangaku
Takashi Wada
Yasuyuki Okuda
Tomoko Sawanobori
机构：
[1] Tohoku University School of Medicine,Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine
[2] Katta General Hospital,Center for Innovative Clinical Medicine
[3] Department of Nephrology and Hypertension,Division of Nephrology and Endocrinology, Graduate School of Medicine
[4] Kawasaki Medical School,Department of Nephrology and Laboratory Medicine
[5] Okayama University Hospital,Data Intelligence Department
[6] The University of Tokyo,Clinical Development Department
[7] Kanazawa University,undefined
[8] Daiichi Sankyo Co.,undefined
[9] Ltd.,undefined
[10] Daiichi Sankyo Co.,undefined
[11] Ltd.,undefined
来源：
Clinical and Experimental Nephrology | 2021年 / 25卷
关键词：
Esaxerenone; Macroalbuminuria; Phase III; Type 2 diabetes; Urinary albumin-to-creatinine ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1070 / 1078
页数：8
相关论文
共 50 条
  • [31] Rituximab therapy for intractable pemphigus: A multicenter, open-label, single-arm, prospective study of 20 Japanese patients
    Yamagami, Jun
    Kurihara, Yuichi
    Funakoshi, Takeru
    Saito, Yasuko
    Tanaka, Ryo
    Takahashi, Hayato
    Ujiie, Hideyuki
    Iwata, Hiroaki
    Hirai, Yoji
    Iwatsuki, Keiji
    Ishii, Norito
    Sakurai, Jun
    Abe, Takayuki
    Takemura, Ryo
    Mashino, Naomi
    Abe, Masahiro
    Amagai, Masayuki
    JOURNAL OF DERMATOLOGY, 2023, 50 (02): : 175 - 182
  • [32] Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
    Haruhito A. Uchida
    Hirofumi Nakajima
    Masami Hashimoto
    Akihiko Nakamura
    Tomokazu Nunoue
    Kazuharu Murakami
    Takeshi Hosoya
    Kiichi Komoto
    Takashi Taguchi
    Takaaki Akasaka
    Kazuhito Shiosakai
    Kotaro Sugimoto
    Jun Wada
    Advances in Therapy, 2022, 39 : 5158 - 5175
  • [33] Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients
    Kurihara, Yuichi
    Yamagami, Jun
    Funakoshi, Takeru
    Ishii, Maki
    Miyamoto, Julia
    Fujio, Yumi
    Kakuta, Risa
    Tanikawa, Akiko
    Aoyama, Yumi
    Iwatsuki, Keiji
    Ishii, Norito
    Hashimoto, Takashi
    Nishie, Wataru
    Shimizu, Hiroshi
    Kouyama, Keisuke
    Amagai, Masayuki
    JOURNAL OF DERMATOLOGY, 2019, 46 (02): : 124 - 130
  • [34] Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
    Ramanan, Ezhil Arasan
    Ravi, Sailatha
    Anbu, K. R. Radha
    Michael, Margaret
    DERMATOLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [35] Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
    Uchida, Haruhito A.
    Nakajima, Hirofumi
    Hashimoto, Masami
    Nakamura, Akihiko
    Nunoue, Tomokazu
    Murakami, Kazuharu
    Hosoya, Takeshi
    Komoto, Kiichi
    Taguchi, Takashi
    Akasaka, Takaaki
    Shiosakai, Kazuhito
    Sugimoto, Kotaro
    Wada, Jun
    ADVANCES IN THERAPY, 2022, 39 (11) : 5158 - 5175
  • [36] Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial
    Zhao, Yi
    Zhang, Xu
    Jin, Chenxing
    Yu, Xiaomin
    Zhang, Min
    Cao, Yang
    Li, Ying
    Wang, Aman
    Shan, Xiu
    Zhang, Jia
    Wang, Juhong
    Yin, Liu
    Tan, Xiaoxin
    Liu, Jiwei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 3277 - 3285
  • [37] Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open-label, multicenter study
    Seino, Yutaka
    Stjepanovic, Aleksandra
    Takami, Akane
    Takagi, Hiroki
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (01) : 127 - 136
  • [38] Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study
    Ito, Sadayoshi
    Itoh, Hiroshi
    Rakugi, Hiromi
    Okuda, Yasuyuki
    Yamakawa, Satoru
    JOURNAL OF HUMAN HYPERTENSION, 2019, 33 (07) : 542 - 551
  • [39] Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study
    Sadayoshi Ito
    Hiroshi Itoh
    Hiromi Rakugi
    Yasuyuki Okuda
    Satoru Yamakawa
    Journal of Human Hypertension, 2019, 33 : 542 - 551
  • [40] Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study
    Song, Kee-Ho
    Kim, Jung Min
    Noh, Jung-Hyun
    Park, Yongsoo
    Son, Hyun-Shik
    Min, Kyong Wan
    Ko, Kyung Soo
    DIABETES & METABOLISM JOURNAL, 2013, 37 (02) : 117 - 124
12345